Workflow
The Beauty Health pany(SKIN) - 2025 Q2 - Quarterly Results
2025-08-07 20:11
Exhibit 99.1 BeautyHealth Reports Second Quarter 2025 Financial Results Raises guidance on strong execution and disciplined cost management Advances science-backed innovation with successful launch of the HydraFillic with Pep9™ Booster Long Beach, Calif., August 7, 2025 – The Beauty Health Company (NASDAQ: SKIN) ("BeautyHealth" or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the second quarter ended June 30, 2025 ("Q2 2025"). "Momentum continued to build in the s ...
Karat(KRT) - 2025 Q2 - Quarterly Results
2025-08-07 20:11
Karat Packaging Reports 2025 Second Quarter Financial Results -- Record Quarterly Net Sales and Net Income -- -- Successful Alternative Sourcing to Navigate Tarif Uncertainty -- CHINO, Calif, August 7, 2025 – Karat Packaging Inc. (Nasdaq: KRT) ("Karat" or the "Company"), a specialty distributor and manufacturer of environmentally friendly, disposable foodservice products and related items, today announced financial results for its 2025 second quarter ended June 30, 2025. Second Quarter 2025 Highlights Guida ...
Natural Grocers by Vitamin tage(NGVC) - 2025 Q3 - Quarterly Results
2025-08-07 20:11
Exhibit 99.1 Lakewood, Colorado, August 7, 2025. Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) today announced results for its third quarter of fiscal 2025 ended June 30, 2025. Highlights for Third Quarter Fiscal 2025 Compared to Third Quarter Fiscal 2024 "Our third quarter performance exceeded our expectations and we again delivered outstanding results across all key metrics including daily average comparable sales growth of 7.4%. We believe that our value offering of high-quality, natural and orga ...
IN8bio(INAB) - 2025 Q2 - Quarterly Report
2025-08-07 20:11
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-39692 IN8BIO, INC. (Exact name of Registrant as specified in its Charter) Delaware 82-5462585 (State or other jurisdiction of in ...
Biodesix(BDSX) - 2025 Q2 - Quarterly Report
2025-08-07 20:11
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Registrant's telephone number, including area code: (303) 417-0500 Securities registered pursuant to Section 12(b) of the Act: | | Trading | | | --- | --- | --- | | Title of each class | Sym ...
Doximity(DOCS) - 2026 Q1 - Quarterly Report
2025-08-07 20:11
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q _________________________________________________________________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001 ...
MAGENTA THERAPEU(MGTA) - 2025 Q2 - Quarterly Report
2025-08-07 20:11
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________________ to _________________ Commission File Number: 001-38541 Dianthus Therapeutics, Inc. (Exact Name of Registrant as Specified in its Charter) | Del ...
Federal Agricultural Mortgage (AGM_A) - 2025 Q2 - Quarterly Results
2025-08-07 20:11
Farmer Mac Reports Second Quarter 2025 Results - Outstanding Business Volume Exceeds $30 Billion - WASHINGTON, D.C., August 7, 2025 — The Federal Agricultural Mortgage Corporation (Farmer Mac; NYSE: AGM and AGM.A), the nation's secondary market provider that increases the accessibility of financing to provide vital liquidity for American agriculture and rural infrastructure, today announced its results for the fiscal quarter ended June 30, 2025. "I'm very pleased to report that we delivered record results a ...
Federal Agricultural Mortgage (AGM) - 2025 Q2 - Quarterly Results
2025-08-07 20:11
Farmer Mac Reports Second Quarter 2025 Results - Outstanding Business Volume Exceeds $30 Billion - WASHINGTON, D.C., August 7, 2025 — The Federal Agricultural Mortgage Corporation (Farmer Mac; NYSE: AGM and AGM.A), the nation's secondary market provider that increases the accessibility of financing to provide vital liquidity for American agriculture and rural infrastructure, today announced its results for the fiscal quarter ended June 30, 2025. "I'm very pleased to report that we delivered record results a ...
Athira Pharma(ATHA) - 2025 Q2 - Quarterly Results
2025-08-07 20:11
Athira Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update Data from Phase 1 clinical trial of ATH-1105 in healthy volunteers showed a favorable safety and tolerability profile; dose proportional pharmacokinetics and CNS penetration support continued clinical development BOTHELL, Wash., August 7, 2025 – Athira Pharma, Inc. (NASDAQ: ATHA), a clinical stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today ...